Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
ActiRhino is a brand of over-the-counter (OTC) products developed by Laboratoires Grimberg for ENT and respiratory health. The product line includes ActiRhino Rhinite allergique (also marketed as ActiRhino Allergie), an approved nasal spray medical device indicated for the symptomatic relief of allergic rhinitis. It contains glycerol, hydroxypropylcellulose, Pollucyanidin-P (derived from blueberry, ivy, and turmeric extracts), and peppermint essential oil, which form a protective, osmotic barrier on the nasal mucosa to trap and eliminate allergens. The brand also encompasses ActiRhino Immunité, a probiotic dietary supplement containing Streptococcus salivarius K12 and vitamin D3 to support natural defenses, and ActiRhino Spray Maux de gorge intenses for sore throat relief.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on ActiRhino.